Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

DSpace/Manakin Repository

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
 
for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK)
(2020) Leukemia, volume 34, issue 10, pp. 2820 - 2820
(Article)
Abstract
Correction to: Leukemia https://doi.org/10.1038/s41375-020-0725-0
Download/Full Text
The full text of this publication is not available.
Version on publisher website for UU-students and staff
Version on publisher website
 
Keywords: Hematology, Oncology, Cancer Research
DOI: https://doi.org/10.1038/s41375-020-0994-7
ISSN: 0887-6924
Publisher: Nature Publishing Group
(Peer reviewed)